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Abstract
Because of their several biological activities, flavonoids may
have an important role in explaining the protective effects
of vegetables, fruit, and, possibly, tea against cancer. The
potential relation between flavonoids and colorectal cancer
risk was investigated using data from a multicentric Italian
case-control study, including 1,953 cases of colorectal
cancers (1,225 colon cancers and 728 rectal cancers) and
4,154 hospital controls admitted for acute nonneoplastic
diseases. We have applied recently published data on the
composition of foods and beverages, in terms of six prin-
cipal classes of flavonoids, on dietary information collected
through a validated food-frequency questionnaire. Odds
ratios (OR) were estimated by multiple logistic regression
models, including terms for sex, age, study center, family
history of colorectal cancer, education, alcohol consumption,
body mass index, physical activity, and energy intake. A
reduced risk of colorectal cancer was found for increasing
intake of isoflavones (OR, 0.76, for the highest versus the
lowest quintile, Ptrend = 0.001), anthocyanidins (OR, 0.67,
P trend < 0.001), flavones (OR, 0.78, Ptrend = 0.004), and
flavonols (OR, 0.64, P trend < 0.001). No significant asso-
ciation was found for flavan-3-ols (OR, 0.98), flavanones
(OR, 0.96), and total flavonoids (OR, 0.97). The estimates did
not substantially differ for colon and rectal cancers, as well
as in strata of sex, age, and body mass index. The findings
of this large study provide support for an inverse associa-
tion of selected classes of flavonoids with colorectal cancer
risk. (Cancer Epidemiol Biomarkers Prev 2006;15(8):1555–8)
Introduction
Flavonoids are a group of over 5,000 compounds contained in
vegetables, fruit, and beverages of plant origin (1). They have
several biological activities that include antimutagenic, anti-
proliferative, and antioxidant effects, as well as involvement
in cell signaling, cell cycle regulation, and angiogenesis (2, 3).
Consequently, flavonoids may have an important role in
explaining the favorable effects of vegetables, fruit, and,
possibly, tea against cancer (4-6). Two reviews (2, 7) of
epidemiologic studies of flavonoid intake and cancer risk
concluded that there is modest evidence that flavonoids are
inversely associated with cancer risk, and that the evidence is
more convincing for the flavonol quercetin and lung cancer.
Four cohort studies investigated the relation between
flavonoids and colorectal cancer and gave inconsistent results.
The Iowa Women’s Health study (8), on a cohort of 34,651
postmenopausal women, including 132 rectal and 635 colon
cancers, found an inverse association between intake of
catechin (a flavan-3-ols) and rectal cancer incidence [odds
ratio (OR), 0.55, 95% confidence intervals (CI), 0.32-0.95 for the
highest versus the lowest quintile], but not for colon cancer
(OR, 1.10; 95% CI, 0.85-1.44). In the Finnish a-Tocopherol,
h-Carotene Study cohort (9) of 27,110 male smokers, including
133 colorectal cancer, there was a borderline direct association
with intake of the sum of flavonols and flavones (OR, 1.70;
95% CI, 1.00-2.70). No significant associations were found in
a Dutch case-cohort study (10) of 3,726 subjects, including
603 cases, with respect to flavonols and the flavone luteolin
(OR, 0.97; 95% CI, 0.71-1.32). Similarly, a Finnish cohort
(11, 12) of about 10,000 men and women, examined at two
different times, with 72 and 90 colorectal cancers, respectively,
found no association with single compounds of flavonols and
flavanones (OR, 0.74; 95% CI, 0.32-1.68; ref. 11) and total
flavonoids (computed as the sum of flavonols, flavanones and
flavones; OR, 0.84; 95% CI, 0.43-1.64; ref. 12). Thus, the
epidemiologic evidence is still inconclusive, also because most
studies included a small number of cases or analyzed the
effects of total flavonoids or single compounds only. More-
over, reliable data on the flavonoid content of foods has
become available only recently (13, 14), and flavonoids have
been categorized in six classes (iisoflavones, anthocyanidins,
flavan-3-ols, flavanones, flavones, and flavonols), according
to their chemical structure and biological activity.
The aim of this article is to investigate the relation between
different classes of flavonoids and colorectal cancer using data
from a large multicentric case-control study of colon and
rectum cancer conducted in Italy (15).
Materials and Methods
A case-control study of colorectal cancer has been conducted
between January 1992 and June 1996 in six Italian areas: the
provinces of Pordenone, Gorizia, Forlı̀, and Latina; and the
urban areas of Milan, Genoa, and Naples (15).
Cases were subjects with histologically confirmed colorectal
cancer diagnosed no longer than 1 year before the interview
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and no previous diagnoses of cancer. Overall, 1,225 subjects
with cancer of the colon (688 men and 537 women, median age
62 years, range 19-74 years) and 728 with cancer of the rectum
or recto-sigmoid junction (437 men and 291 women, median
age 62 years, range 23-74 years) were included (15).
Controls were patients with no history of cancer admitted to
major teaching and general hospitals in the same catchment
areas of cases for acute and nonneoplastic conditions,
unrelated to hormonal or digestive tract diseases or to long-
term modifications of diet. They included 2,073 men and 2,081
women aged 19-74 years (median age 58 years); 27% were
admitted for traumas, 24% for other orthopedic disorders, 18%
for acute surgical conditions, and 31% for eye and other
miscellaneous diseases (15). About 4% of subjects invited to
participate in the study refused.
The same structured questionnaire and coding manual
were used in each center, and interviewers were centrally
trained. The questionnaire included information on socio-
demographic characteristics, lifetime smoking and alcohol-
drinking habits, physical activity, anthropometric measures, a
problem-oriented personal medical history, and family history
of cancer.
Food-Frequency Questionnaire. A reproducible (16) and
valid (17) food-frequency questionnaire was used to assess the
patients’ usual diet during the 2 years before cancer diagnosis
or hospital admission, including 78 foods or food groups, as
well as complex recipes, plus questions aimed at assessing fat
intake and general dietary habits. The average weekly
consumption of each item was recorded.
Energy was computed using an Italian food composition
database, supplemented with other published data (18). We
obtained food and beverage content in terms of six subclasses
of flavonoids (isoflavones, anthocyanidins, flavan-3-ols, flava-
nones, flavones, and flavonols) according to the data recently
published by the U.S. Department of Agriculture (13, 14),
further integrated with other sources (19). Major flavonoids
were genistein and daidzein for isoflavones, cyanidin and
malvidin for anthocyanidines, epicatechin and catechin for
flavan-3-ols, hesperitin and narigerin for flavanones, apigenin
and luteolin for flavones and quercetin, myricetin and
kaempferol for flavonols.
Statistical Analysis.We computed ‘‘calorie-adjusted’’ flavo-
noid intakes using the residualmethod suggested byWillett and
Stampfer (20). The calorie-adjusted flavonoids were categorized
into approximate quintiles based on the controls distribution,
and the corresponding OR and 95% CI were estimated using
unconditional multiple logistic regression models (21). All
models included terms for sex, age (5-year categories), study
center, family history of colorectal cancer, education (<7, 7-11,
z12 years), alcohol consumption (quartiles), body mass index
(quintiles), and occupational physical activity (low, medium,
high). Moreover, calorie-adjusted flavonoids were entered as
continuous variables, with a measurement unit equal to the
difference between the upper cutpoints of the 4th and 1st
quintile. Tests for trend were based on the likelihood ratio test
betweenmodels with and without a linear term for each class of
flavonoids. We also fitted models across strata of sex, age, and
body mass index. Further adjustment for other potential
confounders yielded similar results.
Polytomous logistic regression was used to estimate
separate ORs for colon and rectum cancer and to test for
heterogeneity between the two sites (22).
Table 1. ORs and 95% CIs of 1,953 cases with colorectal cancer and corresponding 4,154 controls, according to energy-
adjusted classes of flavonoids (Italy, 1992-1996)
Mean* (SD) Quintiles
c m2 (P trend) Continuous
b
1 2 3 4 5
Isoflavones (Ag) 25.4 (15.6)
Upper cutpoint 14.4 19.6 25.2 33.9 —
Cases 448 408 369 369 359
ORx (95% CI) 1k 0.86 (0.72-1.02) 0.79 (0.66-0.94) 0.77 (0.65-0.92) 0.76 (0.63-0.91) 10.81 (0.001) 0.92 (0.86-0.99)
Anthocyanidins (mg) 20.0 (18.7)
Upper cutpoint 5.3 11.5 19.4 31.7 —
Cases 429 369 391 364 400
ORx (95% CI) 1k 0.81 (0.68-0.96) 0.78 (0.65-0.93) 0.64 (0.53-0.77) 0.67 (0.54-0.82) 20.02 (<0.001) 0.86 (0.79-0.94)
Flavan-3-ols (mg) 57.4 (54.0)
Upper cutpoint 20.8 34.4 51.7 88.5 —
Cases 378 342 366 395 472
ORx (95% CI) 1k 0.75 (0.63-0.91) 0.75 (0.62-0.90) 0.79 (0.65-0.95) 0.98 (0.82-1.18) 0.11 (0.736) 1.04 (0.98-1.10)
Flavanones (mg) 38.3 (31.8)
Upper cutpoint 12.5 28.7 35.5 67.0 —
Cases 436 378 399 347 393
ORx (95% CI) 1k 0.88 (0.74-1.05) 0.89 (0.75-1.07) 0.80 (0.67-0.96) 0.96 (0.81-1.15) 0.62 (0.430) 0.99 (0.90-1.08)
Flavones (mg) 0.5 (0.3)
Upper cutpoint 0.3 0.4 0.5 0.7 —
Cases 456 388 358 364 387
ORx (95% CI) 1k 0.82 (0.69-0.98) 0.72 (0.61-0.86) 0.76 (0.64-0.91) 0.78 (0.65-0.93) 8.38 (0.004) 0.91 (0.85-0.99)
Flavonols (mg) 21.6 (10.8)
Upper cutpoint 13.2 17.3 22.0 28.5 —
Cases 439 399 389 390 336
ORx (95% CI) 1k 0.80 (0.67-0.95) 0.77 (0.64-0.91) 0.74 (0.62-0.88) 0.64 (0.54-0.77) 21.09 (<0.001) 0.87 (0.80-0.94)
Total flavonoids (mg) 137.8 (78.9)
Upper cutpoint 75.3 108.5 141.6 191.1 —
Cases 383 396 357 373 444
ORx (95% CI) 1k 0.90 (0.75-1.08) 0.79 (0.66-0.94) 0.81 (0.67-0.97) 0.97 (0.81-1.16) 0.45 (0.500) 0.99 (0.92-1.07)
*Mean intake and SD among controls.
cEach quintile included 831 F 1 controls.
bEstimated for an increment of intake equal to the difference between the upper cutpoints of 4th and the 1st quintiles.
xAdjusted for age, sex, study center, family history of colorectal cancer, education, alcohol consumption, body mass index, occupational physical activity, and energy
intake, according to the residual model.
kReference category.
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Results
Table 1 gives the mean daily intake of six classes of flavonoids
and total flavonoids among controls, and the ORs of colorectal
cancer according to quintile of intake. The mean daily intake
was 25.4 Ag for isoflavones, 20.0 mg for anthocyanidins,
57.4 mg for flavan-3-ols, 38.3 mg for flavanones, 0.5 mg for
flavones, 21.6 mg for flavonols, and 137.8 mg for total
flavonoids. A significant inverse relation with colorectal
cancer was observed for isoflavones (OR, 0.76; 95% CI,
0.63-0.91 for the highest versus the lowest quintile), antho-
cyanidins (OR, 0.67; 95% CI, 0.54-0.82), flavones (OR, 0.78;
95% CI, 0.65-0.93), and flavonols (OR, 0.64; 95% CI, 0.54-0.77).
Further adjustment for fruit and vegetable intake did not
materially modify these associations: the OR became 0.77
(95% CI, 0.64-0.92) for isoflavones, 0.78 (95% CI, 0.61-0.99) for
anthocyanidins, 0.80 (95% CI, 0.66-0.96) for flavones, and 0.76
(95% CI, 0.62-0.92) for flavonols. No significant association
emerged for flavan-3-ols (OR, 0.98), flavanones (OR, 0.96), and
total flavonoids (OR, 0.97).
The continuous ORs for an increment equal to the difference
between the upper cutpoint of the fourth and the first quintile
were 0.92 for isoflavones, 0.86 for anthocyanidins, 1.04 for
flavan-3-ols, 0.99 for flavanones, 0.91 for flavones, 0.87 for
flavonols, and 0.99 for total flavonoids.
In Table 2, we analyzed the relation between flavonoids and
cancer of the colon and rectum separately. The estimates did
not differ substantially with respect to the ones for colorectal
cancer, and the heterogeneity terms were not significant.
Table 3 shows the ORs for the continuous terms, in separate
strata of sex, age (<60, z60 years), and body mass index (<25,
z25 kg/m2). Interaction test confirmed that risk patterns were
generally consistent across strata.
Discussion
The present study examined the relation of six classes of
flavonoids (isoflavones, anthocyanidins, flavan-3-ols, flava-
nones, flavones, and flavonols) and total flavonoids with
colorectal cancer. Total flavonoids were not associated with
colorectal cancer; however, we found an inverse association for
isoflavones, anthocyanidins, flavones, and flavonols.
To our knowledge, no other epidemiologic study investi-
gated the role of isoflavones and anthocyanidins on colorectal
cancer, whereas with respect to the remaining classes, our data
are not completely in agreement with some previous studies.
However, most previous investigations examined the effects
of selected compounds only rather than the classes of flavo-
noids that we considered (8-12).
Flavonoids have several important biological functions,
which may be related to cancer risk. In vitro and animal
model systems showed that they influence signal transduction
pathways, stimulate apoptosis, and inhibit inflammation and
proliferation in human cancer cell lines. Selected flavonoids
may also increase transcription of phase II detoxifying
enzymes involved in the clearance of procarcinogenic sub-
stances (2, 23).
Table 2. ORs and 95% CIs of 1,225 cases with colon cancer and 728 cases of rectum cancer and corresponding 4,154



















Isoflavones 0.70 (0.56-0.87) 0.88 (0.81-0.97) 0.81 (0.63-1.04) 0.96 (0.87-1.07) 0.62 (0.432) 1.75 (0.186)
Anthocyanidins 0.69 (0.54-0.89) 0.87 (0.79-0.96) 0.64 (0.48-0.86) 0.84 (0.74-0.96) 0.75 (0.387) 0.54 (0.462)
Flavan-3-ols 1.12 (0.90-1.39) 1.06 (0.98-1.13) 0.81 (0.62-1.06) 1.03 (0.94-1.11) 4.83 (0.028) 0.42 (0.517)
Flavanones 1.05 (0.85-1.29) 1.06 (0.95-1.18) 0.86 (0.66-1.11) 0.90 (0.78-1.03) 1.64 (0.201) 3.12 (0.077)
Flavones 0.77 (0.62-0.95) 0.91 (0.83-1.00) 0.78 (0.61-1.00) 0.92 (0.82-1.02) 0.04 (0.847) 2.30 (0.129)
Flavonols 0.65 (0.53-0.81) 0.89 (0.81-0.97) 0.63 (0.48-0.83) 0.81 (0.72-0.91) 0.03 (0.861) 1.41 (0.236)
Total flavonoids 1.08 (0.87-1.34) 1.04 (0.95-1.14) 0.83 (0.64-1.07) 0.93 (0.82-1.05) 3.10 (0.079) 2.53 (0.111)
NOTE: ORs were estimated using multiple logistic regression models adjusted for sex, age, study center, family history of colorectal cancer, education, alcohol
consumption, body mass index, occupational physical activity, and energy intake, according to the residual model.
*Between colon and rectum.
cEstimated for an increment of intake equal to the difference between the upper cutpoints of 4th and the 1st quintiles.
Table 3. ORs and 95% CIs of 1,953 cases with colorectal cancer and corresponding 4,154 controls, according to energy-
adjusted classes of flavonoids in strata of sex, age, and body mass index (Italy, 1992-1996)
OR* (95% CI)



















Isoflavones 0.90 (0.81-1.00) 0.94 (0.85-1.04) 0.545 0.95 (0.86-1.06) 0.91 (0.83-1.00) 0.457 0.97 (0.88-1.07) 0.90 (0.81-0.99) 0.339
Anthocyanidins 0.90 (0.82-0.98) 0.74 (0.62-0.88) 0.048 0.86 (0.77-0.97) 0.88 (0.80-0.98) 0.763 0.92 (0.82-1.04) 0.85 (0.77-0.94) 0.244
Flavan-3-ols 1.09 (1.01-1.18) 0.98 (0.90-1.07) 0.059 1.04 (0.95-1.13) 1.06 (0.99-1.15) 0.660 1.09 (1.01-1.18) 1.02 (0.94-1.10) 0.232
Flavanones 0.97 (0.86-1.11) 1.00 (0.88-1.14) 0.752 0.96 (0.84-1.09) 1.00 (0.87-1.13) 0.678 1.01 (0.88-1.15) 0.95 (0.84-1.07) 0.499
Flavones 0.91 (0.82-1.01) 0.92 (0.82-1.03) 0.944 0.88 (0.78-0.99) 0.97 (0.88-1.07) 0.200 0.96 (0.86-1.07) 0.90 (0.81-1.00) 0.375
Flavonols 0.88 (0.79-0.98) 0.85 (0.76-0.95) 0.676 0.87 (0.78-0.97) 0.90 (0.81-0.99) 0.678 0.87 (0.78-0.97) 0.90 (0.82-1.00) 0.500
Total flavonoids 1.04 (0.94-1.15) 0.93 (0.82-1.05) 0.158 0.97 (0.87-1.09) 1.03 (0.93-1.14) 0.485 1.06 (0.95-1.19) 0.95 (0.86-1.05) 0.146
NOTE: ORs were estimated using multiple logistic regression models adjusted for sex, age, study center, family history of colorectal cancer, education, alcohol
consumption, body mass index, occupational physical activity, and energy intake, according to the residual model.
*Estimated for an increment of intake equal to the difference between the upper cutpoints of 4th and the 1st quintiles.
cP values of the m21 test of interaction.
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The strengths and weaknesses of hospital-based case-control
studies (21) should be considered in evaluating our results.
Among the limitations are the questions concerning the
adaptability of U.S. flavonoid food composition data to the
Italian diet, and the fact that the questionnaire was not
specifically designed to investigate flavonoids. To our knowl-
edge, no studies using biomarkers of flavonoid intake have
been conducted to date. Thus, it is difficult to evaluate, in this
as well as other studies, the imprecision of exposure
measurement due, among others, to the variation of the food
quantities in the recipes and the variability in plant flavonoid
content attributable to several factors, such as sunlight and
heat. Dietary habits can be influenced by recent diagnosis of
cancer or by the fact that the disease process would have been
well under way during the reference period of the food-
frequency questionnaire (2 years before the diagnosis or
hospital admission). The dietary habits of hospital controls
may differ from those of the general population, but we took
great care to include only patients admitted to hospital for
acute conditions not related to major changes in diet and other
lifestyle factors. Moreover, the same interview setting and
catchment areas for cases and controls, and the al-
most complete participation rate are reassuring. Among
the strengths of this study are the uniquely large data set,
the high intake of fruit and vegetables in this population, the
satisfactory reproducibility and validity of the food-frequency
questionnaire (16, 17), and the ability to control for total energy
intake and other major potential confounding factors.
The Italian population has a high and varied consumption
of vegetables and fruit (24), which has been associated with a
reduced risk of colorectal cancer (15, 25). Although the
causality of this association is still debated, it has been
suggested that some bioactive compounds in fruit and
vegetables, and, among these, flavonoids, account for this
association.
The correlations of the various classes of flavonoids with
fruit ranged between 0.04 and 0.56, and that with total
vegetables between 0.03 and 0.25. Adjustment for isoflavones,
flavones, or flavonols reduced the strength of the inverse
association between vegetables consumption and colorectal
cancer, whereas adjustment for flavonols only reduced the
association with fruit. Conversely, allowance for fruit and
vegetables consumption changed only weakly, if at all, the
observed associations with flavonoids. This suggests that, on
one side, a diet rich in fruit and vegetables does not alone
account for the observed protections, at least for some classes,
and, on the other side, the relation with fruit and vegetables is
not totally explained by flavonoid intake.
Similarly, allowance for vitamin C, vitamin E, carotenoids,
folate, fiber, and macronutrient intake did not modify the
estimated ORs by >10%. In this population, vegetables or bean
soup (37%) and pulses (12%) were the major sources for
isoflavones; wine (65%) and red fruits (22%) for anthocyani-
dins; spinach or chards (27%), vegetables or bean soup (19%)
and tea (14%) for flavones; and apples or pears (18%) and wine
(12%) for flavonols. The lack of association for flavanones,
deriving from citrus fruit (90%), is in accordance with previous
results from this study (15), which did not find a relation
between citrus fruit and colorectal cancer risk. We did not
consider flavonoids deriving from tea separately because tea
consumption was too limited in this population.
In conclusion, we found that some classes of flavonoids, in
particular isoflavones, anthocyanidins, flavones, and flavonols,
significantly decreased the risk of colorectal cancer and could
account, at least in part, for the protective effect of vegetable
and fruit consumption against colorectal cancer in this
population.
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